Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹3,309 Cr
up ₹167 Cr vs Apr 2026
- Stocks held
- 28
- down 2 vs Apr 2026
- Top 10 weight
- 63.6%
- of the portfolio in its ten largest
- Cash & debt
- 6.3%
- cash, money market and debt
- Moves this month
- 0 in · 2 out
- added to 10, trimmed 12
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In May 2026 it disclosed 28 stocks worth ₹3,309 Cr, up ₹167 Cr from Apr 2026. Its largest positions were Sun Pharmaceutical Industries Limited (8.3%), IPCA Laboratories Limited (7.8%), Cipla Limited (7.7%); the ten largest together made up 63.6% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 63.0% of its equity. Cash and debt stood at 6.3%. Compared with Apr 2026 the fund entered 0 new stocks and exited 2.
Against 226 other Sectoral / Thematic funds
Concentration
89%
Top-10 weight is higher than 89% of peers
Breadth
11%
Holds more stocks than 11% of peers
Cash
82%
Holds more cash than 82% of peers
Holdings in May 2026
Download CSVEvery line the fund disclosed, with the change against Apr 2026. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 8.35%
- Δ weight
- down 0.49 pts
- Value
- ₹276 Cr
- Δ value
- down ₹1.4 Cr
- Status
- Trimmed
- Weight
- 7.81%
- Δ weight
- down 0.45 pts
- Value
- ₹259 Cr
- Δ value
- down ₹1.1 Cr
- Status
- Held
- Weight
- 7.68%
- Δ weight
- up 0.12 pts
- Value
- ₹254 Cr
- Δ value
- up ₹16.6 Cr
- Status
- Added
- Weight
- 7.53%
- Δ weight
- up 1.37 pts
- Value
- ₹249 Cr
- Δ value
- up ₹55.7 Cr
- Status
- Added
- Weight
- 6.86%
- Δ weight
- up 0.76 pts
- Value
- ₹227 Cr
- Δ value
- up ₹35.4 Cr
- Status
- Added
- Weight
- 6.34%
- Δ weight
- down 1.00 pts
- Value
- ₹210 Cr
- Δ value
- down ₹20.9 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 6.34%
- Δ weight
- up 3.95 pts
- Value
- ₹210 Cr
- Δ value
- up ₹135 Cr
- Status
- Added
- Weight
- 6.26%
- Δ weight
- up 1.13 pts
- Value
- ₹207 Cr
- Δ value
- up ₹46 Cr
- Status
- Added
- Weight
- 4.81%
- Δ weight
- up 0.08 pts
- Value
- ₹159 Cr
- Δ value
- up ₹10.5 Cr
- Status
- Added
- Weight
- 4.15%
- Δ weight
- down 0.68 pts
- Value
- ₹137 Cr
- Δ value
- down ₹14.6 Cr
- Status
- Trimmed
- Weight
- 3.76%
- Δ weight
- down 2.66 pts
- Value
- ₹125 Cr
- Δ value
- down ₹77.3 Cr
- Status
- Trimmed
- Weight
- 3.70%
- Δ weight
- up 0.34 pts
- Value
- ₹122 Cr
- Δ value
- up ₹16.7 Cr
- Status
- Added
- Weight
- 3.21%
- Δ weight
- down 0.22 pts
- Value
- ₹106 Cr
- Δ value
- down ₹1.6 Cr
- Status
- Trimmed
- Weight
- 2.92%
- Δ weight
- up 0.27 pts
- Value
- ₹96.5 Cr
- Δ value
- up ₹13.4 Cr
- Status
- Added
- Weight
- 2.79%
- Δ weight
- down 0.22 pts
- Value
- ₹92.3 Cr
- Δ value
- down ₹2.2 Cr
- Status
- Trimmed
- Weight
- 2.68%
- Δ weight
- down 0.30 pts
- Value
- ₹88.5 Cr
- Δ value
- down ₹4.9 Cr
- Status
- Trimmed
- Weight
- 2.30%
- Δ weight
- down 0.31 pts
- Value
- ₹76 Cr
- Δ value
- down ₹5.8 Cr
- Status
- Trimmed
- Weight
- 2.06%
- Δ weight
- down 0.10 pts
- Value
- ₹68 Cr
- Δ value
- up ₹31 L
- Status
- Held
- Weight
- 1.58%
- Δ weight
- down 0.23 pts
- Value
- ₹52.2 Cr
- Δ value
- down ₹4.5 Cr
- Status
- Trimmed
- Weight
- 1.51%
- Δ weight
- down 0.51 pts
- Value
- ₹49.8 Cr
- Δ value
- down ₹13.4 Cr
- Status
- Trimmed
- Weight
- 1.31%
- Δ weight
- down 0.05 pts
- Value
- ₹43.3 Cr
- Δ value
- up ₹70 L
- Status
- Added
- Weight
- 1.15%
- Δ weight
- up 0.08 pts
- Value
- ₹38 Cr
- Δ value
- up ₹4.4 Cr
- Status
- Added
- Weight
- 0.98%
- Δ weight
- down 0.04 pts
- Value
- ₹32.4 Cr
- Δ value
- up ₹35 L
- Status
- Added
- Weight
- 0.90%
- Δ weight
- down 0.16 pts
- Value
- ₹29.9 Cr
- Δ value
- down ₹3.4 Cr
- Status
- Trimmed
- Global X Funds - Global X Genomics & Biotechnology ETFFund units
- Weight
- 0.88%
- Δ weight
- up 0.04 pts
- Value
- ₹29 Cr
- Δ value
- up ₹2.6 Cr
- Status
- Added
- Weight
- 0.78%
- Δ weight
- down 0.09 pts
- Value
- ₹25.8 Cr
- Δ value
- down ₹1.5 Cr
- Status
- Trimmed
- Weight
- 0.62%
- Δ weight
- down 0.02 pts
- Value
- ₹20.5 Cr
- Δ value
- up ₹37 L
- Status
- Added
- Weight
- 0.38%
- Δ weight
- up 0.01 pts
- Value
- ₹12.5 Cr
- Δ value
- up ₹95 L
- Status
- Added
- Weight
- 0.20%
- Δ weight
- up 0.02 pts
- Value
- ₹6.5 Cr
- Δ value
- up ₹94 L
- Status
- Added
- Weight
- 0.18%
- Δ weight
- up 0.04 pts
- Value
- ₹6 Cr
- Δ value
- up ₹1.4 Cr
- Status
- Added
What changed, Apr 2026 to May 2026
New New positions (0)
None.
Exited Exited (2)
- MedPlus Health Services Limitedwas 0.5% · ₹16.8 Cr
- Corona Remedies Limitedwas 0.2% · ₹4.7 Cr
Added Biggest additions
- Illumina Incup ₹55.7 Cr (+1.37% pts)
- Gland Pharma Limitedup ₹46 Cr (+1.13% pts)
- Sai Life Sciences Limitedup ₹35.4 Cr (+0.76% pts)
- Vijaya Diagnostic Centre Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Apr 2026, the weight rose most in Healthcare Services (+2.6 pts), and fell most in Healthcare Equipment & Supplies (−0.9 pts) and Pharmaceuticals & Biotechnology (−0.9 pts).
- Healthcare Services19.4% → 22.0%+2.6 pts
- Healthcare Equipment & Supplies10.5% → 9.5%−0.9 pts
- Pharmaceuticals & Biotechnology63.9% → 63.0%−0.9 pts
- Retailing0.6% → 0.0%exited−0.6 pts
- Pharmaceuticals4.2% → 4.0%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | May 2023 | May 2025 | Nov 2025 | Feb 2026 | Apr 2026 | May 2026 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 71.2% | 66.9% | 64.5% | 63.1% | 63.9% | 63.0% |
| Healthcare Services | 13.3% | 17.2% | 17.8% | 19.6% | 19.4% | 22.0% |
| Healthcare Equipment & Supplies | 6.2% | 8.0% | 10.5% | 10.9% | 10.5% | 9.5% |
| Pharmaceuticals | 5.8% | 5.7% | 5.2% | 4.3% | 4.2% | 4.0% |
| Insurance | 2.3% | 1.5% | 1.5% | 1.5% | 1.4% | 1.4% |
Allocation in May 2026change vs Apr 2026
- Pharmaceuticals & Biotechnology (14)63.0%▼ 0.9 pts
- Healthcare Services (7)22.0%▲ 2.6 pts
- Healthcare Equipment & Supplies (3)9.5%▼ 0.9 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, May 2026
6.3%
▲ 3.9 pts vs Apr 2026
- Cash alone
- 6.3%
- cash and net receivables
- A year earlier
- 0.4%
- May 2025 · now ▲ 5.9 pts
- Last 12 months
- 1.0% – 6.3%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.